Yahoo Web Search

Search results

1. • 

     ProQR Therapeutics (NASDAQ:PRQR) shareholders have endured a 83% loss from investing in the stock...

     Simply Wall St. via Yahoo Finance· 1 year ago

     ProQR Therapeutics N.V. (NASDAQ:PRQR) shareholders will doubtless be very grateful to see the share...

2. • 

     ProQR Therapeutics' (NASDAQ:PRQR) investors will be pleased with their impressive 109% return over...

     Simply Wall St. via Yahoo Finance· 10 months ago

     ProQR Therapeutics N.V. (NASDAQ:PRQR) shareholders might understandably be very concerned that the...

3. • 

     Is ProQR (PRQR) Stock a Solid Choice Right Now?

     Zacks via Yahoo Finance· 4 months ago

     One stock that might be an intriguing choice for investors right now is ProQR Therapeutics N.V. PRQR. This is because this security in the Medical -...

4. • 

     While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12%...

     Simply Wall St. via Yahoo Finance· 4 months ago

     Key Insights Significant control over ProQR Therapeutics by individual investors implies that the...

5. • 

     ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are retail investors with 50% stake, while 31% is...

     Simply Wall St. via Yahoo Finance· 9 months ago

     Key Insights The considerable ownership by retail investors in ProQR Therapeutics indicates that...

6. • 

     Investors in ProQR Therapeutics (NASDAQ:PRQR) have unfortunately lost 90% over the last three years

     Simply Wall St. via Yahoo Finance· 2 years ago

     As an investor, mistakes are inevitable. But really big losses can really drag down an overall...

7. • 

     ProQR (PRQR) Reports Q2 Loss, Lags Revenue Estimates

     Zacks via Yahoo Finance· 2 years ago

     ProQR (PRQR) delivered earnings and revenue surprises of 15.38% and 9.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to...

8. • 

     Will ProQR (PRQR) Report Negative Q1 Earnings? What You Should Know

     Zacks via Yahoo Finance· 1 year ago

     ProQR (PRQR) doesn't possess the right combination of the two key ingredients for a likely earnings...

9. • 

     Raymond James Bullish On This Penny Stock's Reprioritized Pipeline

     Benzinga via Yahoo Finance· 2 years ago

     Raymond James upgraded ProQR Therapeutics N.V. (NASDAQ: PRQR) to Outperform based on a high...

10. • 

      This Penny Stock Biotech Offloads Eye Portfolio To Focus On RNA-Editing

      Benzinga via Yahoo Finance· 2 years ago

      ProQR Therapeutics N.V. (NASDAQ: PRQR) said it would look for a partner to take the company’s...